ÂÜÀòÂÒÂ×

Clay Siegall, PhD, is an accomplished leader in the biotechnology field, currently serving as Chairman at Tourmaline Bio since December 2023 and as President and CEO at Immunome, Inc. since October 2023. Prior to these roles, Clay Siegall was President and CEO of MorphImmune from January 2023 to October 2023 and led Seagen as President and CEO from January 1998 until May 2022. Academic credentials include a Doctor of Philosophy in Genetics from The George Washington University and a Bachelor of Science in Zoology from the University of Maryland.